Literature DB >> 18034381

Dispensing opioid substitution treatment: practices, attitudes and intentions of community-based pharmacists.

Peter Lawrinson1, Ann Roche, Hiroe Terao, Phuong-Phi Le.   

Abstract

INTRODUCTION AND AIMS: Community-based pharmacists (CPs) play a pivotal role in the provision of opioid substitution treatment (OST). This study examined practices, experiences, attitudes and intentions of a sample of South Australian pharmacists involved with the provision of OST. DESIGN AND METHODS: A random sample, stratified by geographic location, of 50 SA CPs were administered a telephone survey. The survey included pharmacist and pharmacy details, current practices, problems experienced, attitudes towards and future intentions in relation to the provision of OST.
RESULTS: Pharmacists indicated high levels of support for the OST programme and most (98%) intended to continue providing OST. Sixty-four per cent of all pharmacists, and significantly more rural pharmacists (90%), indicated that they were willing to take on additional clients. Metropolitan pharmacists dosed greater numbers of OST clients (median = 7) than rural pharmacists (median = 4). There was a strong positive correlation between number of regular clients seen and problems experienced by pharmacists. Seventy per cent of pharmacists reported detecting no diversion of pharmacotherapy medication. DISCUSSION AND
CONCLUSIONS: Despite reports to the contrary, pharmacists appear to be generally positively predisposed to providing OST. Policies aimed at retaining pharmacists, particularly in resource poor rural areas, could consider embracing a shared-care approach between general practitioners and pharmacists.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18034381     DOI: 10.1080/09595230701710852

Source DB:  PubMed          Journal:  Drug Alcohol Rev        ISSN: 0959-5236


  6 in total

1.  Provision of opioid substitution therapy services in Australian pharmacies.

Authors:  B B Chaar; J R Hanrahan; C Day
Journal:  Australas Med J       Date:  2011-04-30

2.  Leveraging the role of community pharmacists in the prevention, surveillance, and treatment of opioid use disorders.

Authors:  Paxton Bach; Daniel Hartung
Journal:  Addict Sci Clin Pract       Date:  2019-09-02

3.  Pharmacy stakeholder reports on ethical and logistical considerations in anti-opioid vaccine development.

Authors:  Vincent Wartenweiler; Grace Chung; Amy Stewart; Cody Wenthur
Journal:  BMC Med Ethics       Date:  2021-03-25       Impact factor: 2.652

4.  Examining the cost and impact of dosing fees among clients in opioid agonist treatment: Results from a cross-sectional survey of Australian treatment clients.

Authors:  Emma Zahra; Rory Chen; Suzanne Nielsen; Anh Dam Tran; Thomas Santo; Louisa Degenhardt; Michael Farrell; Jude Byrne; Robert Ali; Briony Larance
Journal:  Drug Alcohol Rev       Date:  2022-02-07

5.  Methadone induction in primary care (ANRS-Methaville): a phase III randomized intervention trial.

Authors:  Perrine Roux; Laurent Michel; Julien Cohen; Marion Mora; Alain Morel; Jean-Francois Aubertin; Jean-Claude Desenclos; Bruno Spire; Patrizia M Carrieri
Journal:  BMC Public Health       Date:  2012-06-28       Impact factor: 3.295

6.  Community pharmacists' experiences in mental illness and addictions care: a qualitative study.

Authors:  Andrea L Murphy; Heather Phelan; Scott Haslam; Ruth Martin-Misener; Stan P Kutcher; David M Gardner
Journal:  Subst Abuse Treat Prev Policy       Date:  2016-01-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.